MENU
TRDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Entrada Therapeutics (TRDA) Earnings Date & Reports

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

TRDA is expected to report earnings to fall 3.77% to -101 cents per share on March 18

Entrada Therapeutics TRDA Stock Earnings Reports
Q4'25
Est.
$-1.02
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.22
Q1'25
Beat
by $0.31
Q4'24
Beat
by $0.70
The last earnings report on November 06 showed earnings per share of -105 cents, missing the estimate of -99 cents. With 388.28K shares outstanding, the current market capitalization sits at 306.52M.
View a ticker or compare two or three
TRDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com